Thyrosin kinase inhibitors: nilotinib. Hematology Meeting Reports, [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.721. Disponível em: https://journals.pagepress.net/hmr/article/view/721. Acesso em: 9 aug. 2026.